Advanced pancreatic neuroendocrine tumor patient treated with everolimus – case report
Journal Title: OncoReview - Year 2012, Vol 2, Issue 3
Abstract
The increasing incidence of gastroenteropancreatic neuroendocrine tumors is caused not exclusively by increasing number of new cases, but also by improved diagnostics. Proper diagnosis and evaluation of tumor differentiation lead to disease prognosis and selection of optimal treatment. Presented clinical case of pancreatic neuroendocrine tumor patient treated with everolimus proves the efficacy of targeted therapy.
Authors and Affiliations
Bogumiła Czartoryska-Arłukowicz
Keywords
Related Articles
- EP ID EP53174
- DOI -
- Views 258
- Downloads 0
Childhood Cancer Survivorship Late Cardiotoxicity, and CV Prevention
Cisplatin-induced cardiotoxicity – two case reports
Cisplatin has been used for over 40 years in various cancer chemotherapies. Toxicity induced by cisplatin-based therapeutic regimens include gastrointestinal toxicity, myelotoxicity, neurotoxicity, ototoxicity and nephro...
Consensus statement on indications for the use of non-pegylated liposomal doxorubicin in patients with lymphomas and concomitant cardivascular diseases
Opposite changes of regulatory T cell blood content may differentially contribute to atherosclerosis or lymphoproliferative disorders
[b]Background[/b]. Chronic autoimmune inflammation in arterial wall may lead to atherosclerosis progression.[b]Objective[/b]. The aim of this study was to investigate the association between Treg, Th17 and B1a cell blood...
Tumor lysis syndrome
Tumor lysis syndrome is a life-threatening oncological emergency occurring in response to chemotherapy or spontaneously as a result of massive and rapid breakdown of malignant cells. The release of their contents into ci...